Moderna
MRNA
#1445
Rank
ยฃ9.28 B
Marketcap
ยฃ24.02
Share price
-3.11%
Change (1 day)
-71.28%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

EPS for Moderna (MRNA)

EPS in 2023 (TTM): -ยฃ7.37

According to Moderna 's latest financial reports the company's current EPS (TTM) is -ยฃ7.05. In 2022 the company made an earnings per share (EPS) of ยฃ16.30 a decrease over its 2021 EPS that were of ยฃ23.37.

EPS history for Moderna from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ7.37-145.23%
2022ยฃ16.30-30.25%
2021ยฃ23.37-1660.82%
2020-ยฃ1.5025.16%
2019-ยฃ1.2037.04%
2018-ยฃ0.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-ยฃ1.30-81.51%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.41-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ2.34-66.85%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ3.17-55.03%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.89-140.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-ยฃ1.31-81.40%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ10.87-254.11%๐Ÿ‡บ๐Ÿ‡ธ USA